Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases Including ALS
|
October 6, 2020
X min read
Scribe Therapeutics to collaborate with Biogen to develop CRISPR-based genetic medicines for neurological diseases, including ALS
|
October 6, 2020
Share on Social
More like this
Media
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
Press
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
